Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × durvalumab × 30 days × Clear all

Phase

Status

Sponsor Class

INDUSTRY 31 OTHER 30 NIH 17 NETWORK 4 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Bevacizumab 3 anlotinib 2 Radiosurgery 2 pyrotinib 1 pomalidomide 1 olaparib 1 ledipasvir, sofosbuvir drug combination 1 ledipasvir 1 hetrombopag 1 durvalumab 1 daclatasvir 1 bemarituzumab 1 atezolizumab 1 Temozolomide 1 Tacrolimus 1 Sofosbuvir 1 Sirolimus 1 Simeprevir 1 Rituximab 1 Ribavirin 1 Raltegravir Potassium 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Prednisone 1 Physical Examination 1 Pemetrexed 1 Pancreatectomy 1 Occult Blood 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03446547 2026-04-14

ASTEROID

Vastra Gotaland Region

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡